Equity Analysis /
United States of America

US : ProQR Therapeutics N.V. - PRQR | Updated Strategy: Prioritizing Ultevursen & Axiomer RNA-Editing Platform

    Contributors
    Timur Ivannikov
    Ryan Deschner
    CGS-CIMB
    13 April 2022
    Published by